Alger Fund Family Report
|
Performance
07-31-19
Total ReturnCategory
Average
| Total Return | 5.11 | 0.59 | 30.77 | -0.20 | 25.72 |
| Category Average | 2.94 | 3.63 | 27.17 | -3.28 | 22.83 |
| Assets for Each Yr* | 15.56 | 13.56 | 15.88 | 15.94 | 20.53 |
*billions
Trailing Returns %
07-31-19
| YTD | 3 Year | 5 Year | |||
|---|---|---|---|---|---|
| Fund Family | 25.72 | 17.70 | 13.08 | ||
Key Stats
07-31-19
| Total Assets* | Min. Investment | Load (% of Assets) | No Load (% of Assets) |
|---|---|---|---|
| $20,531 mil | $1,000 | 28.95 | 71.05 |
| Asset Class | Score | % of Assets | Expense Ratio % | Expense Rating |
| Domestic Stock | 3.5 | 97.24 | 1.28 | Average |
| International Stock | 1.4 | 0.90 | 1.49 | Above Avg |
| Municipal Bond | -- | -- | -- | -- |
| Taxable Bond | -- | -- | -- | -- |
*Doesn't include money market assets.
Top 20 US Holdings | Get Price Quotes
08-23-19
| Sector | YTD Return % | % Net Assets | ||
|---|---|---|---|---|
| Microsoft Corp* | Technology | 32.69 | 6.85 | |
| Alphabet Inc Class C* | Technology | 11.17 | 3.48 | |
| Visa Inc Class A* | Financial Services | 33.38 | 3.45 | |
| Salesforce.com Inc* | Technology | 10.66 | 2.51 | |
| UnitedHealth Group Inc* | Healthcare | -6.62 | 1.87 | |
| Boston Scientific Corp* | Healthcare | 16.50 | 1.49 | |
| Altaba Inc* | Financial Services | 19.99 | 1.43 | |
| Apple Inc* | Technology | 29.90 | 1.40 | |
| Progressive Corp* | Financial Services | 29.06 | 1.00 | |
| Thermo Fisher Scientific Inc* | Healthcare | 20.53 | 0.96 | |
| Cintas Corp* | Industrials | 52.41 | 0.86 | |
| The Home Depot Inc* | Consumer Cyclical | 28.15 | 0.74 | |
| Tandem Diabetes Care Inc* | Healthcare | 75.95 | 0.70 | |
| Dollar Tree Inc* | Consumer Defensive | 5.36 | 0.69 | |
| Insulet Corp* | Healthcare | 94.26 | 0.67 | |
| Chegg Inc* | Consumer Defensive | 40.92 | 0.63 | |
| Lam Research Corp* | Technology | 48.78 | 0.62 | |
| Aptiv PLC* | Consumer Cyclical | 30.81 | 0.57 | |
| WageWorks Inc* | Industrials | 88.88 | 0.53 | |
| Mercury Systems Inc* | Industrials | 79.02 | 0.52 | |
Best 5-Year Relative Performance | More
08-23-19
| Fund Name | 5-Yr Rank | Analyst Report | ||
|---|---|---|---|---|
| Alger Small Cap Focus I | 1 | -- | ||
| Alger Dynamic Opportunities | 3 | -- | ||
| Alger SMid Cap Focus I-2 | 7 | -- | ||
| Alger SMid Cap Focus A | 10 | -- | ||
| Alger Health Sciences A | 12 | -- | ||
Worst 5-Year Relative Performance | More
08-23-19
| Fund Name | 5-Yr Rank | Analyst Report | ||
|---|---|---|---|---|
| Alger International Focus B | 97 | -- | ||
| Alger Global Focus A | 88 | -- | ||
| Alger Mid Cap Growth B | 70 | -- | ||
| Alger Responsible Investing | 67 | -- | ||
| Alger Large Cap Growth I-2 | 65 | -- | ||
Lowest Expenses | More
08-23-19
| Fund Name | Expense Ratio | Analyst Report | ||
|---|---|---|---|---|
| Alger 35 P | 0.40 | -- | ||
| Alger 25 P | 0.75 | -- | ||
| Alger Large Cap Growth I-2 | 0.86 | -- | ||
| Alger Capital Appreciation P | 0.95 | -- | ||
| Alger Growth & Income I-2 | 0.96 | -- | ||
Highest Expenses | More
08-23-19
| Fund Name | Expense Ratio | Analyst Report | ||
|---|---|---|---|---|
| Alger Dynamic Opportunities | 2.63 | -- | ||
| Alger Small Cap Growth B | 2.23 | -- | ||
| Alger Mid Cap Growth B | 2.05 | -- | ||
| Alger International Focus B | 2.01 | -- | ||
| Alger Capital Appreciation B | 1.99 | -- | ||
Longest Manager Tenure | More
08-23-19
| Fund Name | Manager Name | Avg Manager Tenure | ||
|---|---|---|---|---|
| Alger Large Cap Grow | Daniel C. Chung | 17.90 | ||
| Alger Growth & Incom | Daniel C. Chung | 11.70 | ||
| Alger Capital Apprec | Patrick Kelly | 9.60 | ||
| Alger Capital Apprec | Patrick Kelly | 9.60 | ||
| Alger Capital Apprec | Patrick Kelly | 9.60 | ||
Shortest Manager Tenure | More
08-23-19
| Fund Name | Manager Name | Avg Manager Tenure | ||
|---|---|---|---|---|
| Alger 35 P | Daniel C. Chung | 1.40 | ||
| Alger Global Focus A | Gregory M. Jones | 1.40 | ||
| Alger International | Gregory M. Jones | 1.40 | ||
| Alger 25 P | Ankur Crawford | 1.70 | ||
| Alger SMid Cap Focus | Joshua D. Bennett | 2.50 | ||